What fraction of US adults will regularly take GLP-1 drugs in 2030?
32
1.4kṀ17782031
21%
0-5%
14%
6-10%
30%
11-20%
28%
21-30%
3%
31-40%
2%
41-50%
1.2%
51-75%
0.9%
76-100%
I will take the best estimate I can find and try to have the numbers represent the facts at the end of the year.
This question is managed and resolved by Manifold.
Get 
1,000 to start trading!
1,000People are also trading
Related questions
Will a majority government owned company introduce a new GLP-1 drug before 2040?
15% chance
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
81% chance
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
15% chance
More than 30% of US citizens will be on prescription drugs for weight loss by 2031
22% chance
More than 10% of US citizens will be on prescription drugs for weight loss by 2031
63% chance
Will less than 30% of US adults be obese by EOY 2030?
26% chance
Will 10 million Americans be on semaglutide (or yet-to-be-approved equally good or superior alternatives) by the end of 2030?
78% chance
Will a drug company pay >$1m in a class action suit based on their statements about their GLP1 inhibitor by 2026?
38% chance
By 2029, will there be an FDA approval of GLP-1 for a substance use disorder?
86% chance